R W Johnson
Affiliation: University of Bristol
- Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patientRobert W Johnson
Bristol Royal Infirmary and University of Bristol, Bristol, United Kingdom
Drugs Aging 25:991-1006. 2008..In view of the increasing numbers of elderly persons in the population and the poor outcomes of PHN treatment, vaccination against HZ at approximately 60 years of age appears to be an appropriate strategy...
- Similar herpes zoster incidence across Europe: results from a systematic literature reviewSybil Pinchinat
Epidemiology Department, Sanofi Pasteur MSD, 8 Rue Jonas Salk, Lyon, 69007, France
BMC Infect Dis 13:170. 2013..Therefore the aim of this systematic review was to summarize the available data on HZ incidence in Europe and to describe age-specific incidence...
- Prevention of herpes zoster and its painful and debilitating complicationsRobert Johnson
Int J Infect Dis 11:S43-8. 2007..Herpes zoster and complications, such as postherpetic neuralgia (PHN), can have a substantial negative impact on quality of life...
- Zoster-associated pain: what is known, who is at risk and how can it be managed?Robert W Johnson
University of Bristol, Bristol, UK
Herpes 14:30-4. 2007..Effective and long-lasting pain relief in herpes zoster and PHN remains a largely unmet medical need...
- Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccinationRobert W Johnson
University of Bristol, Bristol, UK
Aging Clin Exp Res 21:236-43. 2009..Duration of protection following vaccination is the subject of ongoing surveillance, as is the potential benefit of vaccinating younger and sicker members of the population...
- Postherpetic neuralgia in the elderlyR W Johnson
University of Bristol, Bristol, UK
Int J Clin Pract 63:1386-91. 2009....
- Herpes zoster and postherpetic neuralgiaRobert W Johnson
Bristol, England, UK
Expert Rev Vaccines 9:21-6. 2010..Prevention strategies, such as vaccinating those at greatest risk, may offer the best option for the future...
- Postherpetic neuralgia: epidemiology, pathophysiology and managementRobert W Johnson
Bristol Royal Infirmary, University of Bristol, Bristol, UK
Expert Rev Neurother 7:1581-95. 2007..A zoster vaccine for administration to adults reduces the incidence of HZ and PHN, as well as the burden of illness associated with these conditions...
- Consequences and management of pain in herpes zosterRobert W Johnson
Pain Management Clinic, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom
J Infect Dis 186:S83-90. 2002..Because prevention of PHN requires early recognition and prompt management of patients presenting with herpes zoster, public education and dissemination of information to all health care personnel involved with the disease are essential...
- Herpes zoster in the immunocompetent patient: management of post-herpetic neuralgiaRobert W Johnson
Pain Management Clinic, University of Bristol and Bristol Royal Infirmary, Bristol, UK
Herpes 10:38-45. 2003..This article discusses issues relevant to PHN management and prevention, and provides a review of the pertinent literature...
- Pain following herpes zoster: implications for managementRobert W Johnson
Pain Management Clinic, Level 4, Bristol Royal Infirmary, Bristol BS2 8HW, UK
Herpes 11:63-5. 2004....
- Persistence of varicella-zoster virus viraemia in patients with herpes zosterM L Quinlivan
Department of Infection, The Windeyer Institute, University College London, 46 Cleveland Street, London WC1T 4JF, England, UK
J Clin Virol 50:130-5. 2011..Herpes zoster is caused by the reactivation of varicella-zoster virus from sensory neurons. The commonest complication following zoster is chronic pain termed post herpetic neuralgia...
- Management of herpes zoster (shingles) and postherpetic neuralgiaRobert W Johnson
Pain Management Clinic, Bristol Royal Infirmary, Bristol, UK
Expert Opin Pharmacother 5:551-9. 2004..PHN is common, distressing and often intractable. Good management improves outcome...
- Use of the Rydel-Seiffer graduated tuning fork in the assessment of vibration threshold in postherpetic neuralgia patients and healthy controlsTessa L Whitton
United Bristol Healthcare Trust, Bristol, UK
Eur J Pain 9:167-71. 2005..We aimed to demonstrate a clinically significant increase in vibration threshold in individuals with PHN compared to age-matched controls, using the portable and affordable Rydel-Seiffer graduated tuning fork...
- Recommendations for the management of herpes zosterRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
Clin Infect Dis 44:S1-26. 2007..Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ...
- Global strategies to prevent herpes zoster and its associated complicationsRobert W Johnson
Herpes 14:24. 2007
- Pain following herpes zoster: the influence of changing population characteristics and medical developmentsRobert W Johnson
Pain 128:3-5. 2007
- Geographic and racial aspects of herpes zosterElna M Nagasako
Washington University School of Medicine, St Louis, Missouri, USA
J Med Virol 70:S20-3. 2003..These results suggest that racial group and geographic region may be independent factors associated with age at onset in patients with herpes zoster...
- Treatment of herpes zoster and postherpetic neuralgiaRobert W Johnson
Pain Management Clinic, Bristol Royal Infirmary, Bristol BS2 8HW, University of Rochester Medical Centre, New York, USA
BMJ 326:748-50. 2003
- Risk factors for postherpetic neuralgia in patients with herpes zosterBeth F Jung
University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Neurology 62:1545-51. 2004....
- Tolerability of treatments for postherpetic neuralgiaMark W Douglas
Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Westmead, Australia
Drug Saf 27:1217-33. 2004..Intrathecal methyl prednisolone may be considered for intractable pain but efficacy and safety have not been confirmed...
- Analgesic therapy in postherpetic neuralgia: a quantitative systematic reviewKathleen Hempenstall
Royal Hampshire County Hospital, Winchester, United Kingdom
PLoS Med 2:e164. 2005..Therefore, we have conducted a systematic review and meta-analysis for both efficacy and adverse events of analgesic therapy for PHN...
- Current management of herpes zoster: the European viewAntonio Volpi
Department of Public Health, University of Rome, Rome, Italy
Am J Clin Dermatol 6:317-25. 2005..More needs to be done to educate the general public and increase awareness among primary healthcare providers of the benefits of timely and appropriate pharmacological therapy in patients with herpes zoster...
- The burden of Herpes Zoster: a prospective population based studyFiona T Scott
Skin Virus Laboratory, Institute for Cell and Molecular Science, 25 29 Ashfield Street, E1 1BB, UK
Vaccine 24:1308-14. 2006..PHN occurred in 13.4% of patients. The average overall cost of HZ in the first 6 months was calculated at pound524 per patient. Medical costs were highest in those aged over 65 and societal costs highest in those aged under 65 years...
- Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?Pietro G Coen
Queen Mary s School of Medicine and Dentistry, University of London, Department of Medical Microbiology, 25 29 Ashfield Street, London E1 1BB, UK
Eur J Pain 10:695-700. 2006..Better methods are needed to identify patients over 50 at most risk of PHN that enable GPs to better allocate their resources with respect to HZ treatment...
- Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgiaElna M Nagasako
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, New York, USA
J Am Acad Dermatol 46:834-9. 2002..The results indicate that severe rash is more common in patients with herpes zoster who are older and who have more severe acute pain and confirm that severe rash is a risk factor for prolonged pain...